Clinical Study in the Treatment of Patients With Moderate Course of COVID-19
NCT04842435
·
clinicaltrials.gov ↗
PHASE2,PHASE3
Phase
UNKNOWN
Status
376
Enrollment
OTHER
Sponsor class
Conditions
COVID-19
Interventions
DRUG:
COVID-globulin
DRUG:
Placebo
Sponsor
Microgen